Baudouin S V, Wiggins J, Keogh B F, Morgan C J, Evans T W
Department of Anaesthesia and Intensive Care, Royal Brompton National Heart and Lung Institute, London, UK.
Intensive Care Med. 1993;19(5):290-3. doi: 10.1007/BF01690550.
To study the impact of continuous veno-venous haemofiltration on survival in patients with acute renal failure (ARF) following cardio-pulmonary bypass (CPB) surgery.
A retrospective study of all patients requiring haemofiltration after CPB over a 2 year period.
A 20 bedded, adult cardothoracic intensive care unit in a postgraduate teaching hospital.
35 patients (26 male, age range 24-74 years) required haemofiltration (2.7% of the total number of patients undergoing CPB).
Cardiovascular failure post CPB was the commonest causes of ARF (n = 16). Indications for haemofiltration were uremia (21), oligo-anuria (11), volume overload (2) and hyperkalaemia (1). Mean time from CPB to the initiation of haemofiltration was 8 days (range 0-15 days). Mean urea was 30 mmol/l and creatinine 362 mumol/l immediately prior to treatment. Urea was well-controlled in all patients, although 2 needed haemodiafiltration. Twenty-six patients died during their admission to the ICU (74% mortality). A further 3 patients died during their hospital admission, following discharge from ICU. Outcome was particularly poor in patients with cardiovascular failure following CPB (16 cases, 0 survivors). Survivors tended to commence filtration earlier (mean of 4 vs 7 days for non-survivors) and required treatment for a mean period of 8 days (range 1-26 days). Survival was determined by the number of failed organ systems at the start of haemofiltration. Thus, 100% of patients with single system failure survived, compared to only 10% with 3 or more system failure.
Despite the theoretical advantages of haemofiltration and the effective control of uraemia the mortality associated with ARF following CPB remains high and is probably determined by the number of failed organs systems.
研究持续静脉-静脉血液滤过对体外循环(CPB)手术后急性肾衰竭(ARF)患者生存率的影响。
对2年内所有CPB后需要进行血液滤过的患者进行回顾性研究。
一家研究生教学医院中设有20张床位的成人心胸重症监护病房。
35例患者(26例男性,年龄范围24 - 74岁)需要进行血液滤过(占接受CPB患者总数的2.7%)。
CPB后心血管衰竭是ARF最常见的原因(n = 16)。血液滤过的指征为尿毒症(21例)、少尿-无尿(11例)、容量超负荷(2例)和高钾血症(1例)。从CPB到开始血液滤过的平均时间为8天(范围0 - 15天)。治疗前尿素平均为30 mmol/L,肌酐平均为362 μmol/L。所有患者的尿素均得到良好控制,尽管有2例需要血液透析滤过。26例患者在入住ICU期间死亡(死亡率74%)。另有3例患者在从ICU出院后住院期间死亡。CPB后发生心血管衰竭的患者预后特别差(16例,无幸存者)。幸存者往往开始滤过的时间更早(幸存者平均4天,非幸存者平均7天),且平均需要治疗8天(范围1 - 26天)。生存率取决于血液滤过开始时衰竭器官系统的数量。因此,单系统衰竭的患者100%存活,而3个或更多系统衰竭的患者仅10%存活。
尽管血液滤过具有理论上的优势且能有效控制尿毒症,但CPB后ARF相关的死亡率仍然很高,可能由衰竭器官系统的数量决定。